Correspondence 0001104659-23-121368 from ProSomnus, Inc. (CIK 0001934064)
ProSomnus, Inc. (CIK 0001934064)
Date: Nov. 27, 2023 · CIK: 0001934064 · Accession: 0001104659-23-121368
AI Filing Summary & Sentiment
File numbers found in text: 333-275241
Referenced dates: November 15, 2023
Letter
Wilson Sonsini Goodrich & Rosati Professional Corporation
650 Page Mill Road
Palo Alto, California 94304-1050
O: 650.493.9300
F: 650.493.6811
November 27, 2023
Via EDGAR and Secure File Transfer
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Nicholas O’Leary
Margaret Schwartz
Re:
ProSomnus Inc.
Registration Statement on Form S-1
Filed November 1, 2023
File No. 333-275241
Ladies and Gentlemen:
On behalf of our client, ProSomnus, Inc. (“ProSomnus” or the “Company”), we submit this letter in response to the comment from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”) contained in its letter dated November 15, 2023, relating to the above referenced Registration Statement on Form S-1 filed with the Commission on November 1, 2023 (the “Registration Statement”). We are concurrently submitting via EDGAR this letter and an amendment to the Registration Statement (the “Amendment No. 1”). For the Staff’s reference, both a clean copy of Amendment No. 1 and a copy marked to show all changes from the Registration Statement.
In this letter, we have recited the comment from the Staff in italicized, bold type and have followed the comment with the Company’s response.
Securities and Exchange Commission
November 27, 2023
Page 2
General
1. In relation to the 5,454,524 shares of common stock issuable upon the exercise of the transaction warrants issued in the September 20, 2023, private placement, please tell us your basis for registering the offering of these shares on a primary basis. In this regard, we note that these shares and warrants were issued pursuant to the exemptions provided in Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder, and are exercisable within one year. Please consider the rationale set out in Securities Act Section C&DI Questions 139.09, 239.15, and 103.04.
The Company respectfully acknowledges the Staff’s comment and has revised the Registration Statement to reflect the registration of the offering of the 5,454,524 shares of common stock issuable upon the exercise of the transaction warrants issued in the September 20, 2023 private placement on a secondary basis rather than on a primary basis.
*****
Securities and Exchange Commission
November 27, 2023
Page 3
Please direct any questions regarding the Company’s responses or the Registration Statement to Andrew Hoffman at (650) 849-3240 or ahoffman@wsgr.com or Austin March at (512) 338-5410 or amarch@wsgr.com.
Sincerely,
WILSON SONSINI GOODRICH & ROSATI
Show Raw Text
CORRESP
1
filename1.htm
Wilson Sonsini Goodrich
& Rosati Professional Corporation
650 Page Mill Road
Palo Alto, California 94304-1050
O: 650.493.9300
F: 650.493.6811
November 27, 2023
Via EDGAR and Secure File Transfer
U.S. Securities and Exchange
Commission
Division of Corporation Finance
Office of Industrial Applications
and Services
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Nicholas O’Leary
Margaret Schwartz
Re:
ProSomnus Inc.
Registration Statement on Form S-1
Filed November 1, 2023
File No. 333-275241
Ladies and Gentlemen:
On behalf of our client, ProSomnus,
Inc. (“ProSomnus” or the “Company”), we submit this letter in response to the comment from the staff
(the “Staff”) of the Securities and Exchange Commission (the “Commission”) contained in its letter
dated November 15, 2023, relating to the above referenced Registration Statement on Form S-1 filed with the Commission on November 1,
2023 (the “Registration Statement”). We are concurrently submitting via EDGAR this letter and an amendment to the Registration
Statement (the “Amendment No. 1”). For the Staff’s reference, both a clean copy of Amendment No. 1 and a copy
marked to show all changes from the Registration Statement.
In this letter, we have recited
the comment from the Staff in italicized, bold type and have followed the comment with the Company’s response.
Securities and Exchange Commission
November 27, 2023
Page 2
General
1. In relation to the 5,454,524 shares of common stock issuable upon the exercise of the transaction
warrants issued in the September 20, 2023, private placement, please tell us your basis for registering the offering of these shares on
a primary basis. In this regard, we note that these shares and warrants were issued pursuant to the exemptions provided in Section 4(a)(2)
of the Securities Act and Regulation D promulgated thereunder, and are exercisable within one year. Please consider the rationale set
out in Securities Act Section C&DI Questions 139.09, 239.15, and 103.04.
The Company respectfully
acknowledges the Staff’s comment and has revised the Registration Statement to reflect the registration of the offering of the
5,454,524 shares of common stock issuable upon the exercise of the transaction warrants issued in the September 20, 2023 private placement
on a secondary basis rather than on a primary basis.
*****
Securities and Exchange Commission
November 27, 2023
Page 3
Please direct any questions
regarding the Company’s responses or the Registration Statement to Andrew Hoffman at (650) 849-3240 or ahoffman@wsgr.com or Austin
March at (512) 338-5410 or amarch@wsgr.com.
Sincerely,
WILSON SONSINI GOODRICH & ROSATI
Professional Corporation
/s/ Andrew Hoffman
Andrew Hoffman
cc:
Leonard Liptak, ProSomnus, Inc.
Brian Dow, ProSomnus, Inc.
Austin March, Wilson Sonsini Goodrich & Rosati, P.C.